OpGen, Inc. (OPGN)
OTCMKTS · Delayed Price · Currency is USD
15.65
-0.05 (-0.32%)
Dec 31, 2025, 3:16 PM EST
OpGen Market Cap
OpGen has a market cap or net worth of $160.13 million as of December 31, 2025. Its market cap has increased by 877.81% in one year.
Market Cap
160.13M
Enterprise Value
161.61M
Revenue
9.00M
Ranking
n/a
PE Ratio
42.28
Stock Price
$15.65
Market Cap Chart
Since May 5, 2015, OpGen's market cap has increased from 51.90M to 160.13M, an increase of 208.57%. That is a compound annual growth rate of 11.15%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 30, 2025 | 158.12M | 2,539.49% |
| Dec 31, 2024 | 5.99M | 42.44% |
| Dec 29, 2023 | 4.21M | -44.45% |
| Dec 30, 2022 | 7.57M | -80.56% |
| Dec 31, 2021 | 38.95M | -15.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Veradigm | 773.31M |
| Glass House Brands | 723.19M |
| Elite Pharmaceuticals | 503.55M |
| Nika Pharmaceuticals | 395.17M |
| American Oncology Network | 394.40M |
| Northwest Biotherapeutics | 355.02M |
| CytoDyn | 325.20M |
| Silence Therapeutics | 290.49M |